AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
Recruiting now · Phase 3
Conditions studied: Epithelial Ovarian Cancer
In brief
The intention of the study is to demonstrate superiority of AZD5335 versus standard of care by assessment of progression-free survival (PFS) in women with high-grade, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer, expressing high or low FRα levels.
Key facts
- Study ID
- NCT07218809
- Run by
- AstraZeneca
- People needed
- 1100
- Starts
- 2025-12-29
- Expected to finish
- 2029-12-27
- Last updated by the study team
- 2026-07-21
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Research Site — Germantown, Tennessee, United States (enrolling)
- Research Site — Tyler, Texas, United States (enrolling)
- Research Site — Blue Ash, Ohio, United States (enrolling)
- Research Site — Portland, Oregon, United States (enrolling)
- Research Site — San Antonio, Texas, United States (enrolling)
- Research Site — Jupiter, Florida, United States (enrolling)
- Research Site — Miami, Florida, United States (enrolling)
- Research Site — Chapel Hill, North Carolina, United States (enrolling)
- Research Site — Birmingham, Alabama, United States (enrolling)
- Research Site — Dayton, Ohio, United States (enrolling)
- Research Site — Gainesville, Florida, United States (enrolling)
- Research Site — Urbana, Illinois, United States (enrolling)
- Research Site — Fort Wayne, Indiana, United States (enrolling)
- Research Site — Indianapolis, Indiana, United States (enrolling)
- Research Site — Louisville, Kentucky, United States (enrolling)
- Research Site — Towson, Maryland, United States (enrolling)
- Research Site — Burlington, Massachusetts, United States (enrolling)
- Research Site — Washington D.C., District of Columbia, United States (enrolling)
- Research Site — Minneapolis, Minnesota, United States (enrolling)
- Research Site — Springfield, Missouri, United States (enrolling)
- Research Site — Billings, Montana, United States (enrolling)
- Research Site — Omaha, Nebraska, United States (enrolling)
- Research Site — Las Vegas, Nevada, United States (enrolling)
- Research Site — Peoria, Illinois, United States (enrolling)
- Research Site — Fairfax, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.